Where Science, Education, and Therapeutics Converge
The QOL Project™
QOL Project™ is the research and development engine behind a new model of precision medicine and regenerative aesthetics. Every formulation, every training protocol, and every clinical innovation that reaches a patient, a physician, or a partner originates here.
Founded by Dr. Christie Prendergast, DO FACS and her pHD team, QOL Project™ transforms over a decade of frontline clinical data and proprietary compounds into scalable science, structured education, and next-generation therapeutics.
ABOUT QOL PROJECT
Three pillars, one mission
Research & Development
Translational research on peptide therapeutics, regenerative formulations, and precision medicine protocols, grounded in real-world clinical outcomes.
Learn more
Education
QOL Institute™ certifies physicians in peptide therapy, precision medicine, and regenerative aesthetics, setting a new standard for clinical training.
Learn more
Therapeutics
Proprietary formulations and protocols, developed and protected under QOL Project™.
Learn more
Built for what's next
QOL Project™ is redefining how compounds get validated against human biology, replacing guesswork with organoid modeling, AI-driven analysis, and personalized biomarkers. This is the next generation of precision medicine and regenerative aesthetics, built on evidence rather than assumption.